Group 1B phospholipase A2 inactivation suppresses atherosclerosis and metabolic diseases in LDL receptor-deficient mice

This publication has 19 references indexed in Scilit:

• The phospholipase A₂ inhibitor methyl indoxam suppresses diet‐induced obesity and glucose intolerance in mice
  British Journal of Pharmacology, 2009
• Group 1B Phospholipase A2–Mediated Lysophospholipid Absorption Directly Contributes to Postprandial Hyperglycemia
  Diabetes, 2006
• Linkage and potential association of obesity-related phenotypes with two genes on chromosome 12q24 in a female dizygous twin cohort
  European Journal of Human Genetics, 2006
• The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes
  Expert Opinion on Pharmacotherapy, 2005
• Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
  Science, 2004
• Protection against diet-induced obesity and obesity- related insulin resistance in Group 1B PLA₂-deficient mice
  American Journal of Physiology-Endocrinology and Metabolism, 2002
• Pancreatic Phospholipase A2 Activity in Acute Pancreatitis: a Prognostic Marker for Early Identification of Patients at Risk
  Clinical Chemistry and Laboratory Medicine (CCLM), 2002
• Compensatory phospholipid digestion is required for cholesterol absorption in pancreatic phospholipase A2–Deficient mice
  Gastroenterology, 2001
• Molecular structure and tissue-specific expression of the mouse pancreatic phospholipase A2 gene
  Gene, 2000
• Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis.
  Gut, 1993